Viking Global Investors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $349M | Hold |
29,993,708
| – | – | 1.01% | 44 |
|
|
2025
Q1 | $223M | Hold |
29,993,708
| – | – | 0.71% | 50 |
|
|
2024
Q4 | $180M | Hold |
29,993,708
| – | – | 0.58% | 47 |
|
|
2024
Q3 | $154M | Hold |
29,993,708
| – | – | 0.56% | 47 |
|
|
2024
Q2 | $109M | Hold |
29,993,708
| – | – | 0.42% | 53 |
|
|
2024
Q1 | $96.3M | Hold |
29,993,708
| – | – | 0.36% | 54 |
|
|
2023
Q4 | $147M | Hold |
29,993,708
| – | – | 0.54% | 43 |
|
|
2023
Q3 | $163M | Hold |
29,993,708
| – | – | 0.66% | 40 |
|
|
2023
Q2 | $201M | Hold |
29,993,708
| – | – | 0.82% | 41 |
|
|
2023
Q1 | $265M | Hold |
29,993,708
| – | – | 1.24% | 26 |
|
|
2022
Q4 | $229M | Hold |
29,993,708
| – | – | 1.15% | 28 |
|
|
2022
Q3 | $214M | Hold |
29,993,708
| – | – | 0.99% | 35 |
|
|
2022
Q2 | $243M | Hold |
29,993,708
| – | – | 1.11% | 32 |
|
|
2022
Q1 | $416M | Hold |
29,993,708
| – | – | 1.68% | 21 |
|
|
2021
Q4 | $842M | Hold |
29,993,708
| – | – | 2.42% | 12 |
|
|
2021
Q3 | $1.02B | Hold |
29,993,708
| – | – | 2.8% | 7 |
|
|
2021
Q2 | $1.23B | Hold |
29,993,708
| – | – | 3.72% | 6 |
|
|
2021
Q1 | $1.21B | Hold |
29,993,708
| – | – | 3.6% | 6 |
|
|
2020
Q4 | $1.77B | Sell |
29,993,708
-3,500,000
| -10% | -$207M | 4.88% | 3 |
|
|
2020
Q3 | $1.63B | Hold |
33,493,708
| – | – | 5.88% | 2 |
|
|
2020
Q2 | $1.62B | Hold |
33,493,708
| – | – | 7% | 2 |
|
|
2020
Q1 | $930M | Sell |
33,493,708
-4,912,899
| -13% | -$136M | 4.84% | 5 |
|
|
2019
Q4 | $1.15B | Hold |
38,406,607
| – | – | 5.38% | 3 |
|
|
2019
Q3 | $1.19B | Hold |
38,406,607
| – | – | 6.18% | 2 |
|
|
2019
Q2 | $1.86B | Buy |
+38,406,607
| New | +$1.86B | 8.32% | 1 |
|